Helen Sabzevari
CIK: 0001724195
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PRECIGEN, INC.
Discretionary Trading P&L
Holdings
Transaction History (18 total)
- Aug 23, 2026PGEN
PRECIGEN, INC.
Tax Payment(F)Direct10.2K shares at avg. $7.20$73K - Aug 23, 2026PGEN
PRECIGEN, INC.
Exercise(M)Direct20.8K shares- - Jun 29, 2026PGEN
PRECIGEN, INC.
Sale(S)Direct346.8K shares at avg. $5.89$2.0M - Jun 29, 2026PGEN
PRECIGEN, INC.
Exercise(M)Direct346.8K shares at avg. $2.33$808K - May 28, 2026PGEN
PRECIGEN, INC.
Sale(S)Direct119.3K shares at avg. $4.36$520K - May 23, 2026PGEN
PRECIGEN, INC.
Exercise(M)Direct250K shares- - Apr 20, 2026PGEN
PRECIGEN, INC.
Award(A)DirectRestricted Stock Units
410K shares- - Apr 20, 2026PGEN
PRECIGEN, INC.
Award(A)DirectOption to Purchase Common Stock (Right to Buy)
1.4M shares- - Mar 18, 2026PGEN
PRECIGEN, INC.
Exercise(M)Direct321.1K shares- - Mar 18, 2026PGEN
PRECIGEN, INC.
Award(A)DirectRestricted Stock Units
321.1K shares- - Sep 12, 2025PGEN
PRECIGEN, INC.
Award(A)DirectPerformance Stock Units
825K shares- - Jun 26, 2025PGEN
PRECIGEN, INC.
Award(A)DirectRestricted Stock Units
500K shares- - May 23, 2025PGEN
PRECIGEN, INC.
Award(A)DirectOption to Purchase Common Stock (Right to Buy)
1M shares- - May 16, 2025PGEN
PRECIGEN, INC.
Tax Payment(F)Direct521.2K shares at avg. $1.45$756K - May 16, 2025PGEN
PRECIGEN, INC.
Exercise(M)Direct1.1M shares- - Apr 17, 2025PGEN
PRECIGEN, INC.
Award(A)DirectRestricted Stock Units
1.1M shares- - Jan 29, 2025PGEN
PRECIGEN, INC.
Tax Payment(F)Direct287K shares at avg. $1.30$373K - Jan 29, 2025PGEN
PRECIGEN, INC.
Award(A)Direct825K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 23, 2026 | PGEN PRECIGEN, INC. | Tax Payment(F) | 10,184 | $7.20 | $73,325 | Direct |
| Aug 23, 2026 | PGEN PRECIGEN, INC. | Exercise(M) | 20,833 | - | $0 | Direct |
| Jun 29, 2026 | PGEN PRECIGEN, INC. | Sale(S) | 346,836 | $5.89 | $2,042,864 | Direct |
| Jun 29, 2026 | PGEN PRECIGEN, INC. | Exercise(M) | 346,836 | $2.33 | $808,128 | Direct |
| May 28, 2026 | PGEN PRECIGEN, INC. | Sale(S) | 119,250 | $4.36 | $519,930 | Direct |
| May 23, 2026 | PGEN PRECIGEN, INC. | Exercise(M) | 250,000 | - | $0 | Direct |
| Apr 20, 2026 | PGEN PRECIGEN, INC. | Award(A) Restricted Stock Units | 410,000 | - | - | Direct |
| Apr 20, 2026 | PGEN PRECIGEN, INC. | Award(A) Option to Purchase Common Stock (Right to Buy) | 1,366,000 | - | - | Direct |
| Mar 18, 2026 | PGEN PRECIGEN, INC. | Exercise(M) | 321,100 | - | $0 | Direct |
| Mar 18, 2026 | PGEN PRECIGEN, INC. | Award(A) Restricted Stock Units | 321,100 | - | - | Direct |
| Sep 12, 2025 | PGEN PRECIGEN, INC. | Award(A) Performance Stock Units | 825,000 | - | - | Direct |
| Jun 26, 2025 | PGEN PRECIGEN, INC. | Award(A) Restricted Stock Units | 500,000 | - | - | Direct |
| May 23, 2025 | PGEN PRECIGEN, INC. | Award(A) Option to Purchase Common Stock (Right to Buy) | 1,000,000 | - | - | Direct |
| May 16, 2025 | PGEN PRECIGEN, INC. | Tax Payment(F) | 521,224 | $1.45 | $755,775 | Direct |
| May 16, 2025 | PGEN PRECIGEN, INC. | Exercise(M) | 1,079,137 | - | - | Direct |
| Apr 17, 2025 | PGEN PRECIGEN, INC. | Award(A) Restricted Stock Units | 1,079,137 | - | - | Direct |
| Jan 29, 2025 | PGEN PRECIGEN, INC. | Tax Payment(F) | 286,967 | $1.30 | $373,057 | Direct |
| Jan 29, 2025 | PGEN PRECIGEN, INC. | Award(A) | 825,000 | - | - | Direct |
1-18 of 18 transactions
About Sabzevari Helen
Sabzevari Helen (SEC CIK 0001724195) files insider reports with the SEC as President and CEO of PRECIGEN, INC. (PGEN).
Signal8 holds 12 ownership filings by Sabzevari Helen, all Form 4s, filed between Feb 3, 2025 and Aug 25, 2026. Those filings report 18 transactions, from Jan 29, 2025 to Aug 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Sabzevari Helen's filings is in GERMANTOWN, MD.
Recent filings by Sabzevari Helen
- Aug 23, 2026: Tax withholding of PGEN shares (Form 4, code F).
- Aug 23, 2026: Option exercise of PGEN shares (Form 4, code M).
- Jun 29, 2026: Open-market sale of PGEN shares (Form 4, code S).
- Jun 29, 2026: Option exercise of PGEN shares (Form 4, code M).
- May 28, 2026: Open-market sale of PGEN shares (Form 4, code S).
Other insiders filing for PRECIGEN, INC. (PGEN)
- Thomasian Harry Jr., Chief Financial Officer
- KINDLER JEFFREY B, Director
- AGEE NANCY H, Director
- Lehr Donald P., Chief Legal Officer
- Shah Rutul R, Chief Operating Officer
- Tennant Phil, Chief Commercial Officer